Tackling Parkinson's: Pharma Two B tests FDC in Phase IIb

As the world gets ready to mark Parkinson's Disease Awareness Month in April, the harsh reality for patients is the fact there remains no cure and few effective treatments for the chronic, progressive neurological condition, which affects up to one in every 100 people over 60 years.